Liver Tumors of Unidentified Primary: are all HCC or HCC-CCA?
Contents
Chair
Tania Roskams
Professor, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.
Speaker(s)
Tania Roskams
Professor, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.
Topic: Histopathology of liver tumours: all primary and metastatic tumours
Topic: Histopathology of liver tumours: all primary and metastatic tumours
Swan N. Thung
Professor of Pathology, Molecular and Cell-Based Medicine; Director of Hepatopathology Division, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Topic: HCC Mimickers
Topic: HCC Mimickers
Vincent Vandecaveye
Professor at the Catholic University of Leuven; Supervising staff radiologist at the division of abdominal/gynaecological imaging in the department of radiology at the University Hospitals Leuven, Leuven, Belgium.
Topic: Radiological diagnosis of liver carcinoma
Topic: Radiological diagnosis of liver carcinoma
Daniela Sia
Assistant Professor of Medicine, Liver Diseases, Liver Cancer Program, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Topic: Understanding liver tumors: new insights into molecular subtypes
Topic: Understanding liver tumors: new insights into molecular subtypes
Cipriani Federica
Medical Doctor of Department of Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Topic: Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines
Topic: Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines
Jaekyung Cheon
Assistant Professor of Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Topic: Systemic therapy against combined HCC-CCA
Topic: Systemic therapy against combined HCC-CCA
Programme
Programme
- Time (Belgium)
- Speakers
- Topics
- 14:00 - 14:10
- Tania Roskams
- Welcome Speech
- 14:10 - 14:30
- Tania Roskams
- Histopathology of liver tumours: all primary and also metastatic tumours
- 14:30 - 14:50
- Swan N. Thung
- HCC Mimickers
- 14:50 - 15:10
- Vincent Vandecaveye
- Radiological diagnosis of liver carcinoma
- 15:10 - 15:30
- Daniela Sia
- Understanding liver tumors: new insights into molecular subtypes
- 15:30 - 15:45
- Tania Roskams
- Discussion (Q&A)
- 15:45 - 16:05
- Cipriani Federica
- Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines
- 16:05 - 16:25
- Jaekyung Cheon
- Systemic therapy against combined HCC-CCA
- 16:25 - 16:40
- Tania Roskams
- Discussion (Q&A)
Moments
Presentation
Tania Roskams, Professor, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.
Topic: Histopathology of liver tumours: all primary and metastatic tumours
NaN
Swan N. Thung, Professor of Pathology, Molecular and Cell-Based Medicine; Director of Hepatopathology Division, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Topic: HCC Mimickers
NaN
Vincent Vandecaveye, Professor at the Catholic University of Leuven; Supervising staff radiologist at the division of abdominal/gynaecological imaging in the department of radiology at the University Hospitals Leuven, Leuven, Belgium.
Topic: Radiological diagnosis of liver carcinoma
NaN
Daniela Sia, Assistant Professor of Medicine, Liver Diseases, Liver Cancer Program, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Topic: Understanding liver tumors: new insights into molecular subtypes
NaN
Cipriani Federica, Medical Doctor of Department of Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Topic: Surgery for HCC-ICC: milestone changes in the last 2 decades potentially affecting current guidelines
NaN
Jaekyung Cheon, Assistant Professor of Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
Topic: Systemic therapy against combined HCC-CCA
NaN
